Published Paper Details:

More than half a billion people around the world continue to be affected by cardiovascular diseases, which accounted for 20.5 million deaths in 20211 - close to a third of all deaths globally and an overall increase on the estimated 121 million CVD deaths. An essential therapeutic method for a variety of cardiac illnesses is the efficient delivery of medications to the heart. Targeted medication delivery techniques have become more and more promising thanks to Nano carriers. Specific target locations, suitable drug delivery vehicles, and efficient drug delivery systems are key factors in the efficacy of Nano carriers for delivering medications to therapeutic areas in the heart focusing on ligands. Effective targeted medication delivery implies that a drug is specifically deposited in the heart after administration with little impact on other organs. Nano carrier may provide a solution to more effective treatment of disease, with better prognoses and a reduced side effect profile. This review provide a brief overview about Nanoparticle used for TDDS to the heart including their advantages, features, application and future prospective.